Case of sorafenib-induced thyroid storm

J Clin Oncol. 2013 Jun 1;31(16):e262-4. doi: 10.1200/JCO.2012.46.7142. Epub 2013 Apr 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Gland Neoplasms / drug therapy
  • Adrenal Gland Neoplasms / secondary
  • Aged
  • Amiodarone / administration & dosage
  • Anti-Arrhythmia Agents / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Atrial Fibrillation / drug therapy
  • Biomarkers / blood
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary*
  • Drug Administration Schedule
  • Fatal Outcome
  • Heart Arrest / etiology
  • Humans
  • Kidney Neoplasms / pathology
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Muscle Neoplasms / drug therapy
  • Muscle Neoplasms / secondary
  • Niacinamide / administration & dosage
  • Niacinamide / adverse effects
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / administration & dosage
  • Phenylurea Compounds / adverse effects*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Respiratory Aspiration / complications
  • Sorafenib
  • Thyroid Crisis / blood
  • Thyroid Crisis / chemically induced*
  • Thyroid Crisis / diagnosis
  • Thyroid Hormones / blood*

Substances

  • Anti-Arrhythmia Agents
  • Antineoplastic Agents
  • Biomarkers
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Thyroid Hormones
  • Niacinamide
  • Sorafenib
  • Protein-Tyrosine Kinases
  • Amiodarone